Arrow`s Generic Lenalidomide Receives Approval in the U.S.
06 Mar 2023 //
FDA
Blueprint Announces Benefits Of GAVRETO In RET-Mutant Medullary Thyroid Cancer
20 Sep 2020 //
PRNEWSWIRE
Enforcement Report - Week of August 29, 2018
29 Aug 2018 //
FDA
Enforcement Report - Week of August 1, 2018
01 Aug 2018 //
FDA
Arrow Pharma acquires Australian operations of Amneal Pharma
01 Sep 2017 //
ECONOMIC TIMES
Second valium manufacturer Arrow recalls medication after fears of tampering
09 Jun 2017 //
SMH